The prevalence of cancer cachexia varies among different cancer types, with pancreatic, hepatobiliary, and oesophagogastric cancer having notably high rates Assess the patient for cancer cachexia in ...

PDAC patients are frequently affected by cachexia characterized by muscle mass and strength loss (sarcopenia) contributing to patient frailty and poor therapeutic response. This study assesses the ...